Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733512 · ClinicalTrials.gov registry record
Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)
A clinical trial of Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT00733512: Completed study of Cataract, sponsored by Alcon Research.
NCT00733512 is a study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 146 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00733512, a study of Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.
Primary Outcome
Uncorrected Visual Acuity (UCVA) and Best Spectacle Corrected Visual Acuity (BSCVA) at distance (4 meters) and near at preferred distance and measured by logMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA). A lower logMAR value indicates better visual acuity.
Conditions Studied
Interventions
- DEVICE ReSTOR
Study Locations (1)
Texas
- Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-03 |
What the finished NCT00733512 record still lists
NCT00733512 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which ReSTOR is the first listed.
NCT00733512 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00733512 about?
NCT00733512 is a clinical study titled "Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)". To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.
What is the current status of trial NCT00733512?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2007-06. Estimated completion is 2008-03.
What conditions does trial NCT00733512 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00733512?
The interventions under investigation include: ReSTOR (DEVICE).
Who is sponsoring clinical trial NCT00733512?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00733512 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00733512's enrollment target sits among peer trials
146 32nd of 83 higher than 52 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia